Ejection – Newsemia

Angiotensin Receptor-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction: Lessons from PARAGON-HF.

NewsemiaAugust 4, 2020

by NewsemiaAugust 4, 202000

Related Articles Angiotensin Receptor-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction: Lessons from PARAGON-HF. Eur J Heart Fail. 2020 Aug 02;: Authors: Vaduganathan M,...

Cardiology

Determinants and prognostic value of echocardiographic first-phase ejection fraction in aortic stenosis

NewsemiaAugust 2, 2020

by NewsemiaAugust 2, 202000

Objective First-phase ejection fraction (EF1) is a novel measure of early left ventricular systolic dysfunction. We investigated determinants of EF1 and its prognostic value in...

Gastroenterology

Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction

NewsemiaJuly 26, 2020

by NewsemiaJuly 26, 202000

Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction Source link...

Cardiology

Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients with Heart Failure and Preserved Ejection Fraction: The VIP-HF study.

NewsemiaJuly 20, 2020

by NewsemiaJuly 20, 202000

Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients with Heart Failure and Preserved Ejection Fraction: The VIP-HF study. Eur J Heart Fail. 2020 Jul...

Cardiology

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction

NewsemiaJuly 17, 2020

by NewsemiaJuly 17, 202000

Objective To determine the prognostic value of atrial fibrillation (AF) in patients with heart failure (HF) and preserved, mid-range or reduced ejection fraction (EF). Methods...

Cardiology

Enhanced Response to Drug-Induced QT Interval Lengthening in Patients with Heart Failure with Preserved Ejection Fraction.

NewsemiaJuly 1, 2020

by NewsemiaJuly 1, 202000

Related Articles Enhanced Response to Drug-Induced QT Interval Lengthening in Patients with Heart Failure with Preserved Ejection Fraction. J Card Fail. 2020 Jun 24;: Authors:...

Cardiology

Trajectories of Waist-to-Hip Ratio and Adverse Outcomes in Heart Failure with Mid-Range Ejection Fraction.

NewsemiaJune 23, 2020

by NewsemiaJune 23, 202000

Related Articles Trajectories of Waist-to-Hip Ratio and Adverse Outcomes in Heart Failure with Mid-Range Ejection Fraction. Obes Facts. 2020 Jun 22;:1-14 Authors: Gao F, Wan...

Cardiology

Sustained adherence to ESC guideline-recommended medications is associated with lower long-term mortality in heart failure and reduced ejection fraction: Insights from the EPICAL2 cohort.

NewsemiaMay 29, 2020

by NewsemiaMay 29, 202007

Related Articles Sustained adherence to ESC guideline-recommended medications is associated with lower long-term mortality in heart failure and reduced ejection fraction: Insights from the EPICAL2...

Cardiology

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction

NewsemiaApril 19, 2020

by NewsemiaApril 19, 202003

Sudden cardiac death and arrhythmia-related events in patients with non-ischaemic dilated cardiomyopathy (NICM) have been significantly reduced over the last couple of decades as a...

Cardiology

Heart Failure With Preserved Ejection Fraction: The Quest for a Blood Pressure Goal

NewsemiaApril 10, 2020

by NewsemiaApril 10, 202007

Heart Failure With Preserved Ejection Fraction: The Quest for a Blood Pressure Goal Source link...

Cardiology

Renal iodine123-metaiodobenzylguanidine scintigraphy relates to muscle sympathetic nervous activity in heart failure with reduced ejection fraction.

NewsemiaApril 10, 2020

by NewsemiaApril 10, 2020029

Related Articles Renal iodine123-metaiodobenzylguanidine scintigraphy relates to muscle sympathetic nervous activity in heart failure with reduced ejection fraction. Auton Neurosci. 2020 Mar 31;226:102671 Authors: Okabe...

Cardiology

Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan

NewsemiaApril 9, 2020

by NewsemiaApril 9, 202008

AbstractBackground Guidelines recommend targeting systolic blood pressure (SBP) <130 mm Hg in heart failure with preserved ejection fraction (HFpEF) with limited data. Objectives This study sought to determine...

Cardiology

Can the development of atrial fibrillation in patients with ischemic heart failure with low ejection fraction be predicted?

NewsemiaApril 3, 2020

by NewsemiaApril 3, 2020032

Related Articles Can the development of atrial fibrillation in patients with ischemic heart failure with low ejection fraction be predicted? North Clin Istanb. 2020;7(1):18-24 Authors:...

Cardiology

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.

NewsemiaMarch 30, 2020

by NewsemiaMarch 30, 202005

Related Articles Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2020 Mar 28;: Authors: Armstrong PW, Pieske B, Anstrom...

Cardiology

Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction

NewsemiaMarch 23, 2020

by NewsemiaMarch 23, 2020011

AbstractBackground Better risk stratification strategies are needed to enhance clinical care and trial design in heart failure with preserved ejection fraction (HFpEF). Objectives The purpose...

AI/ML

Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes.

NewsemiaMarch 10, 2020

by NewsemiaMarch 10, 2020010

Related Articles Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes. JACC Basic Transl Sci. 2019 Nov;4(7):831-840 Authors:...

Cardiology

Cardiorespiratory fitness and heart rate recovery predict sudden cardiac death independent of ejection fraction

NewsemiaFebruary 29, 2020

by NewsemiaFebruary 29, 2020013

Objective To evaluate whether cardiorespiratory fitness (CRF) and heart rate recovery (HRR) associate with the risk of sudden cardiac death (SCD) independently of left ventricular...

Cardiology

Heartbeat: can machine learning improve outcomes in patients with heart failure with preserved ejection fraction?

NewsemiaFebruary 25, 2020

by NewsemiaFebruary 25, 2020013

Machine learning offers the opportunity to gain new insights into clinical cardiovascular disease as shown in the paper in this issue of Heart on novel...

Cardiology

Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning

NewsemiaFebruary 22, 2020

by NewsemiaFebruary 22, 2020040

Objective Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome. We aimed to derive HFpEF phenotype-based groups (‘phenogroups’) based on clinical and echocardiogram...

Cardiology

Bernie Sanders Is Back: Is His Heart Healthy? Why Is His Ejection Fraction Not Reported?

NewsemiaFebruary 15, 2020

by NewsemiaFebruary 15, 202006

While campaigning in Las Vegas last October, Vermont Senator Bernie Sanders began experiencing tightness in his chest. He was rushed to a hospital where he...

Newsemia

Tag: Ejection

Angiotensin Receptor-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction: Lessons from PARAGON-HF.

Determinants and prognostic value of echocardiographic first-phase ejection fraction in aortic stenosis

Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction

Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients with Heart Failure and Preserved Ejection Fraction: The VIP-HF study.

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction

Enhanced Response to Drug-Induced QT Interval Lengthening in Patients with Heart Failure with Preserved Ejection Fraction.

Trajectories of Waist-to-Hip Ratio and Adverse Outcomes in Heart Failure with Mid-Range Ejection Fraction.

Sustained adherence to ESC guideline-recommended medications is associated with lower long-term mortality in heart failure and reduced ejection fraction: Insights from the EPICAL2 cohort.

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction

Heart Failure With Preserved Ejection Fraction: The Quest for a Blood Pressure Goal

Renal iodine123-metaiodobenzylguanidine scintigraphy relates to muscle sympathetic nervous activity in heart failure with reduced ejection fraction.

Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan

Can the development of atrial fibrillation in patients with ischemic heart failure with low ejection fraction be predicted?

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.

Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction

Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes.

Cardiorespiratory fitness and heart rate recovery predict sudden cardiac death independent of ejection fraction

Heartbeat: can machine learning improve outcomes in patients with heart failure with preserved ejection fraction?

Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning

Bernie Sanders Is Back: Is His Heart Healthy? Why Is His Ejection Fraction Not Reported?

COVID-19